Updated:
Ajinomoto
Ajinomoto was established in 1909 in Tokyo by Saburosuke Suzuki II and Dr. Kikunae Ikeda. The company began with commercial production tied to the...
Ajinomoto
Ajinomoto was established in 1909 in Tokyo by Saburosuke Suzuki II and Dr. Kikunae Ikeda. The company began with commercial production tied to the identification of umami as a distinct taste. The firm produces consumer food items and develops amino acid applications. It operates factories in the Philippines, Brazil, and Japan. Holdings include the Ajinomoto Headquarters Building in Tokyo and the Ajinomoto Build-up Film product line used in electronics. Geographic reach covers Asia and Latin America. The company lists three foundations focused on dietary culture, scholarships, and general philanthropy. It maintains membership in WIPO GREEN for climate initiatives. No investment deployment figures or portfolio company stakes appear in available records.
General information
Firm type
Corporate Investor
Year founded
1909
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Principals
Taro Fujie
President and CEO
Saburosuke Suzuki II
Founder
Dr. Kikunae Ikeda
Founder
Sector focus
Frequently asked questions
Who runs investment decisions at Ajinomoto?
Taro Fujie holds the role of president and CEO. Investment activity occurs within the corporate structure rather than through a dedicated external vehicle.
Does Ajinomoto participate in fund commitments or only direct deals?
Available information shows direct ownership of manufacturing assets and product lines. No fund commitments are documented.
Where does the underlying wealth come from?
Wealth originates from commercial operations in food manufacturing and amino acid technology that began in 1909.
Does Ajinomoto maintain philanthropic structures, and how are they separated?
The firm operates the Ajinomoto Foundation for Dietary Culture, the Ajinomoto Scholarship Foundation, and The Ajinomoto Foundation as separate entities.
What is Ajinomoto's known posture on co-investments alongside external GPs?
No co-investment activity with external general partners is recorded in public sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: